NEW YORK (GenomeWeb News) – Proteome Sciences preliminarily reported Tuesday that its revenues more than doubled year over year for full-year 2011.

For the year ended Dec. 31, 2011, the UK company recorded revenues of £1.0 million ($1.6 million), up from £450,088 for full-year 2010. The 2010 figure excludes the exceptional £9.5 million in income from the Sanofi-Aventis warranty claim settlement, Proteome Sciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.